BNB Plus Corp is a biotechnology company executing a yield focused BNB digital asset treasury strategy, while also commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
Management Team
Stock Information
Shareholder Info – Investor Relations
BNB Plus Corp.
50 Health Sciences Drive
Stony Brook, NY 11790
investor@adnas.com | 631.240.8800
John Ragozzino Jr.
CFA
BnB@icrinc.com
Transfer Agent
Equiniti
6201 15th Ave.
Brooklyn, New York 11219
Tel: 718.921.8210
Fax: 718.921.8355
https://equiniti.com/us/ast-access
For additional information, please click here.
SEC Counsel
McDermott Will & Emery LLP
One Vanderbilt Avenue
New York, NY 10017-3852
T: 212-547-5400
https://www.mwe.com/locations/new-york/
.
BNB Plus Corp. is not able to purchase shares on your behalf, and it is not possible for you to purchase shares directly from us. Please contact a stockbroker, bank, or independent financial advisor, who should be able to act on your behalf.
Auditor
CBIZ
10 Melville Park Road
Melville, NY 11790
tel: 631 414 4000
fax: 631 414 4001
http://www.marcumllp.com
Board of Directors
BNB Plus Corp’s Board of Directors consists of individuals with proven leadership skills, broad management experience
in
established companies, and their reputation as independent thinkers.
With experience in fields ranging from Bioagriculture to Zoology, the company will continue to benefit from the
Board’s diversity of experience and opinions.
